Search
Searched for . Search results: 2042
What is driving the obesity pandemic? Ultraprocessed foods, our bodies being fooled by them, and it’s easier to gain weight than lose it
New class of GLP-1 drugs, when more widely available, could help interrupt the pandemic.
ViewAccounts 2025
Annual Report and Financial Statements for the World Obesity Federation, for year ending 31 December 2025.
ViewStudy estimates thousands of deaths could be prevented by halving ultra-processed food consumption
New research suggests that between 23-38% of cardiovascular deaths are attributable to ultra-processed food consumption.
ViewStudy shows how GLP-1 obesity drugs are associated with reduced systemic inflammation beyond their anti-obesity effects
GLP-1 class of obesity drugs associated with a marked reduction in systemic inflammation beyond anti-obesity effects.
ViewAnnual Report 2025
Annual Review and Report for the World Obesity Federation, for the year ending 31 December 2025.
ViewStudy is first to show behavioural weight loss interventions reduce the risk of obesity-related cancers in people living with overweight and obesity
Behavioural weight loss interventions reduce the risk of obesity-related cancers in people living with obesity.
ViewCoca-Cola’s “sportswashing” of health-harming products at World Cup & previous major sporting events including Olympic Games amplified by digital media
New research exposes new marketing tactics by Coca-Cola and calls for greater scrutiny of its health-harming activities.
ViewInternet searches on weight-loss drugs have soared 25-fold in past decade
25-fold increase in internet searches for obesity medication sparks concern, study shows.
ViewSCOPE School Mexico
In conjunction with ICO 2026, SCOPE School is coming to Mexico City, Mexico, this 14 July.
ViewObesity Lived Experience Global Summit 2026
At ICO 2026, this Summit will bring together people living with obesity or related conditions
View